|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the UNH 10-Q filed May 7, 2009. Cost of Products Sold Cost of products sold increased due to increased prescription volume at our Prescription Solutions reporting segment. These excerpts taken from the UNH 10-K filed Feb 11, 2009. Cost of Products Sold Cost of products sold increased due to increased prescription volume at our Prescription Solutions reporting segment, primarily related to the Fiserv Health acquisition. Cost of Products Sold Cost of products sold increased in 2007 primarily due to costs associated with increased pharmacy sales at Prescription Solutions as a result of providing prescription drug benefit services to an additional four million Ovations Medicare Advantage and Part D members in 2007. This excerpt taken from the UNH 10-Q filed Nov 7, 2008. Cost of Products Sold Cost of products sold for the three and nine months ended September 30, 2008 totaled $387 million and $1.1 billion, respectively, an increase of $181 million, or 88%, and $508 million, or 91%, over the comparable 2007 periods, due to increased prescription volume at our Prescription Solutions segment, primarily related to the Fiserv Health acquisition. This excerpt taken from the UNH 10-Q filed Aug 7, 2008. Cost of Products Sold Cost of products sold for the three and six months ended June 30, 2008 totaled $353 million and $678 million, respectively, an increase of $172 million, or 95%, and $327 million, or 93%, over the comparable 2007 periods, due to increased prescription volume at our Prescription Solutions segment, primarily related to the Fiserv Health acquisition. This excerpt taken from the UNH 10-Q filed May 2, 2008. Cost of Products Sold Cost of products sold for the three months ended March 31, 2008 totaled $325 million, an increase of $155 million, or 91%, over the comparable 2007 period, due to increased sales levels at our Prescription Solutions segment, primarily related to acquisitions. This excerpt taken from the UNH 10-K filed Feb 21, 2008. Cost of Products Sold Cost of products sold in 2006 totaled $599 million, an increase of $510 million over 2005. This increase was primarily due to increased pharmacy sales at Prescription Solutions, which was acquired in December 2005 with the purchase of PacifiCare. This excerpt taken from the UNH 10-Q filed Nov 1, 2007. Cost of Products Sold Cost of products sold for the three and nine months ended September 30, 2007 totaled $206 million and $557 million, respectively, an increase of $55 million, or 36%, and $126 million, or 29%, over the comparable periods of 2006. This was primarily due to costs associated with increased pharmacy sales at our PBM business.
29
Table of ContentsThis excerpt taken from the UNH 10-Q filed Aug 6, 2007. Cost of Products Sold Cost of products sold for the three and six months ended June 30, 2007 totaled $181 million and $351 million, respectively, an increase of $38 million, or 27%, and $71 million, or 25%, over the comparable periods of 2006. This was primarily due to costs associated with increased pharmacy sales at our PBM business. This excerpt taken from the UNH 10-Q filed May 9, 2007. Cost of Products Sold Cost of products sold during the first quarter of 2007 totaled $170 million, an increase of $33 million, or 24%, over the comparable period of 2006. This was primarily due to costs associated with increased pharmacy sales at our PBM business. This excerpt taken from the UNH 10-Q filed Mar 6, 2007. Cost of Products Sold Cost of products sold during the first quarter of 2006 totaled $137 million, an increase of $121 million over the comparable period of 2005. This was primarily due to pharmacy sales at our PBM business, which was acquired in December 2005 with the purchase of PacifiCare. This excerpt taken from the UNH 10-Q filed Mar 6, 2007. Cost of Products Sold Cost of products sold for the three and six months ended June 30, 2006 totaled $143 million and $280 million, respectively, an increase of $131 million and $252 million over the comparable 2005 periods. This was primarily due to pharmacy sales at our PBM business, which was acquired in December 2005 with the purchase of PacifiCare. This excerpt taken from the UNH 10-K filed Mar 6, 2007. Cost of Products Sold Cost of products sold in 2005 totaled $89 million, an increase of $35 million over 2004. This was primarily due to pharmacy sales at our PBM business, which was acquired in December 2005 with the purchase of PacifiCare, and increased costs associated with sales under the interim government-sponsored drug card program.
38
Table of ContentsThis excerpt taken from the UNH 10-Q filed Mar 6, 2007. Cost of Products Sold Cost of products sold for the three and nine months ended September 30, 2006 totaled $151 million and $431 million, respectively, an increase of $135 million and $387 million over the comparable 2005 periods. This was primarily due to pharmacy sales at our PBM business, which was acquired in December 2005 with the purchase of PacifiCare. | EXCERPTS ON THIS PAGE:RELATED TOPICS for UNH: |
| |||||||
